Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/175
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBailey, Nolaen
dc.date.accessioned2015-06-03T01:58:42Zen
dc.date.available2015-06-03T01:58:42Zen
dc.date.issued2014-09en
dc.identifier.urihttp://hdl.handle.net/11434/175en
dc.description.abstractAim: HybridArc™ (Brainlab, AG) is a treatment technique blending aperture-enhanced dynamic conformal arc therapy with discrete IMRT beams. This study dosimetrically compares HybridArc with IMRT in Stereotactic Body Radiotherapy (SBRT) for spinal tumours. Method: In a retrospective study of 10 patients with metastatic thoracic or lumbar spinal disease, the dosimetric results of a 7 field IMRT distribution were compared against a single 320–340 degree HybridArc™ distribution containing three to four fixed-port IMRT fields. Planning was performed using the Brainlab iPlan RT Dose 4.5.3 platform. Treatment plans were designed to deliver a homogeneous dose of 40 Gy to Planning Target Volume (PTV) Spine with a simultaneous integrated-boost to the tumour to a total dose of 50 Gy. Planning objectives were 90% of prescribed dose to cover 100% of PTVs, while minimising the maximum spinal cord point dose to 34 Gy. A comparison of target and Organ At Risk dose volume histograms, maximum and minimum target dose, and conformity index was used to evaluate each planning technique. Planning time, mean beam-on time and Monitor Units were also analysed. Results: Both IMRT and HybridArc™ produced clinically acceptable treatment plans; HybridArc™ incorporating 4 IMRT beams generally produced superior results when compared to HybridArc™ incorporating 3 IMRT beams. Superior PTV coverage and lower maximum dose was achieved more often with IMRT plans compared with HybridArc™. The conformity index for the IMRT distributions was generally lower, correlating to improve sparing of normal tissues. Planning times were less for IMRT plans due to the time taken to optimise both aperture and IMRT beams for HybridArc™. Conclusion: Epworth Radiation Oncology will continue to use IMRT as its modality of choice for SBRT of spinal tumours as the dosimetric qualities are generally superior to HybridArc™, and efficiencies are achieved in the planning process.en
dc.subjectRadiation therapyen
dc.subjectSpinal Neoplasmsen
dc.subjectStereotactic Body Radiotherapyen
dc.subjectTherapeuticsen
dc.subjectTherapyen
dc.subjectTreatmenten
dc.subjectNeoplasmsen
dc.subjectTumorsen
dc.subjectNeoplasiaen
dc.subjectNeoplasmen
dc.subjectRetrospective Studyen
dc.subjectRetrospective Studiesen
dc.titleA comparison of intensity modulated radiation therapy (IMRT) and HybridArc (TM) treatment plans for spinal tumoursen
dc.typeConference Paperen
dc.identifier.doihttp://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&pi=125821en
dc.description.conferencename2014 Combined Scientific Meeting: Imaging and Radiation in Personalised Medicineen
dc.description.conferencelocationMelbourne, Victoria, Australiaen
dc.type.contenttypeTexten
Appears in Collections:Cancer Services

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.